#3 Neurostimulation for Psychiatric Disorders

Overview

Neurostimulation, such as deep brain stimulation (DBS), is emerging as a significant treatment option for millions of Americans who are suffering from treatment-resistant depression and treatment-resistant obsessive-compulsive disorder.
 
Investigational results continue to show effectiveness of neurostimulation in the treatment of resistant forms of depression and OCD. There is also a growing acceptance of DBS for treatment of Parkinson's, essential tremor, and dystonia.

Where Are They Now

Neurostimulation, such as deep brain stimulation (DBS), is emerging as a significant treatment option for millions of Americans who are suffering from treatment-resistant depression and treatment-resistant obsessive-compulsive disorder. Studies of DBS in the treatment of resistant forms of depression continue to show promise despite the technique’s failure to receive FDA approval.

DBS has been approved by the FDA for the treatment of dystonia, essential tremors, and drug-resistant obsessive-compulsive disorder. Current research is focusing on the use of DBS for multiple clinical applications, such as the treatment of Tourette syndrome, drug-resistant epilepsy, and obesity. DBS is also being investigated in the area of stroke recovery, with the first-in-human trial beginning in early 2017.

Get In Touch With Us